Cargando…

Cost-effectiveness analysis of infant feeding modalities for virally suppressed mothers in Canada living with HIV

OBJECTIVE: The aim of the study was to determine whether exclusive breastfeeding or exclusive formula feeding is more cost-effective when a Canadian mother with HIV is adherent to antiretroviral therapy and has full virologic suppression. DESIGN: Current Canadian guidelines recommend that mothers wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Keshmiri, Reyhaneh, Coyte, Peter C., Laporte, Audrey, Sheth, Prameet M., Loutfy, Mona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571366/
https://www.ncbi.nlm.nih.gov/pubmed/31169687
http://dx.doi.org/10.1097/MD.0000000000015841
_version_ 1783427399676854272
author Keshmiri, Reyhaneh
Coyte, Peter C.
Laporte, Audrey
Sheth, Prameet M.
Loutfy, Mona
author_facet Keshmiri, Reyhaneh
Coyte, Peter C.
Laporte, Audrey
Sheth, Prameet M.
Loutfy, Mona
author_sort Keshmiri, Reyhaneh
collection PubMed
description OBJECTIVE: The aim of the study was to determine whether exclusive breastfeeding or exclusive formula feeding is more cost-effective when a Canadian mother with HIV is adherent to antiretroviral therapy and has full virologic suppression. DESIGN: Current Canadian guidelines recommend that mothers with HIV practice exclusive formula feeding. This contradicts the updated World Health Organization (WHO) guidelines which recommend that mothers with HIV should breastfeed for ≥12 months while receiving support for antiretroviral therapy adherence. Due to the economic and health risks and benefits associated with each modality, there remains expert disagreement on whether the WHO recommendations should be adopted in high-income countries. METHODS: A microsimulation model was developed to estimate lifetime costs and effectiveness (i.e., infant's quality-adjusted life years) of a hypothetical group of 1,000,000 initially healthy, HIV-negative infants, if the mother with HIV was on antiretroviral therapy with full virologic suppression and either exclusive breastfeeding or exclusive formula feeding. The model was developed from the economic perspective of the Ontario Ministry of Health, taking into account direct costs associated with infant feeding modality as well as related indirect costs born out of the child's lifetime health outcomes. Uncertainties related to model parameters were evaluated using one-way and probabilistic sensitivity analyses. RESULTS: In comparison to exclusive formula feeding, exclusive breastfeeding was the dominant feeding modality (i.e., less costly and more effective) yielding cost-savings of $13,812 per additional quality-adjusted life year gained. Neither one-way nor probabilistic sensitivity analyses altered the conclusions. CONCLUSIONS: Despite the risk of HIV transmission, exclusive breastfeeding was more cost-effective than exclusive formula feeding. These findings merit review of current infant feeding guidelines for mothers with HIV living in high-income countries.
format Online
Article
Text
id pubmed-6571366
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-65713662019-07-22 Cost-effectiveness analysis of infant feeding modalities for virally suppressed mothers in Canada living with HIV Keshmiri, Reyhaneh Coyte, Peter C. Laporte, Audrey Sheth, Prameet M. Loutfy, Mona Medicine (Baltimore) Research Article OBJECTIVE: The aim of the study was to determine whether exclusive breastfeeding or exclusive formula feeding is more cost-effective when a Canadian mother with HIV is adherent to antiretroviral therapy and has full virologic suppression. DESIGN: Current Canadian guidelines recommend that mothers with HIV practice exclusive formula feeding. This contradicts the updated World Health Organization (WHO) guidelines which recommend that mothers with HIV should breastfeed for ≥12 months while receiving support for antiretroviral therapy adherence. Due to the economic and health risks and benefits associated with each modality, there remains expert disagreement on whether the WHO recommendations should be adopted in high-income countries. METHODS: A microsimulation model was developed to estimate lifetime costs and effectiveness (i.e., infant's quality-adjusted life years) of a hypothetical group of 1,000,000 initially healthy, HIV-negative infants, if the mother with HIV was on antiretroviral therapy with full virologic suppression and either exclusive breastfeeding or exclusive formula feeding. The model was developed from the economic perspective of the Ontario Ministry of Health, taking into account direct costs associated with infant feeding modality as well as related indirect costs born out of the child's lifetime health outcomes. Uncertainties related to model parameters were evaluated using one-way and probabilistic sensitivity analyses. RESULTS: In comparison to exclusive formula feeding, exclusive breastfeeding was the dominant feeding modality (i.e., less costly and more effective) yielding cost-savings of $13,812 per additional quality-adjusted life year gained. Neither one-way nor probabilistic sensitivity analyses altered the conclusions. CONCLUSIONS: Despite the risk of HIV transmission, exclusive breastfeeding was more cost-effective than exclusive formula feeding. These findings merit review of current infant feeding guidelines for mothers with HIV living in high-income countries. Wolters Kluwer Health 2019-06-07 /pmc/articles/PMC6571366/ /pubmed/31169687 http://dx.doi.org/10.1097/MD.0000000000015841 Text en Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0
spellingShingle Research Article
Keshmiri, Reyhaneh
Coyte, Peter C.
Laporte, Audrey
Sheth, Prameet M.
Loutfy, Mona
Cost-effectiveness analysis of infant feeding modalities for virally suppressed mothers in Canada living with HIV
title Cost-effectiveness analysis of infant feeding modalities for virally suppressed mothers in Canada living with HIV
title_full Cost-effectiveness analysis of infant feeding modalities for virally suppressed mothers in Canada living with HIV
title_fullStr Cost-effectiveness analysis of infant feeding modalities for virally suppressed mothers in Canada living with HIV
title_full_unstemmed Cost-effectiveness analysis of infant feeding modalities for virally suppressed mothers in Canada living with HIV
title_short Cost-effectiveness analysis of infant feeding modalities for virally suppressed mothers in Canada living with HIV
title_sort cost-effectiveness analysis of infant feeding modalities for virally suppressed mothers in canada living with hiv
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571366/
https://www.ncbi.nlm.nih.gov/pubmed/31169687
http://dx.doi.org/10.1097/MD.0000000000015841
work_keys_str_mv AT keshmirireyhaneh costeffectivenessanalysisofinfantfeedingmodalitiesforvirallysuppressedmothersincanadalivingwithhiv
AT coytepeterc costeffectivenessanalysisofinfantfeedingmodalitiesforvirallysuppressedmothersincanadalivingwithhiv
AT laporteaudrey costeffectivenessanalysisofinfantfeedingmodalitiesforvirallysuppressedmothersincanadalivingwithhiv
AT shethprameetm costeffectivenessanalysisofinfantfeedingmodalitiesforvirallysuppressedmothersincanadalivingwithhiv
AT loutfymona costeffectivenessanalysisofinfantfeedingmodalitiesforvirallysuppressedmothersincanadalivingwithhiv